Quantcast

Latest Pneumococcal vaccine Stories

9cead16037c31effa279a502d22dd59d
2011-07-07 14:05:59

By Richard Harth, The Biodesign Institute On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State...

b1ca5215bfb6f45f0474729f087b23d8
2011-06-30 09:20:09

By Richard Harth, The Biodesign Institute A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia. Now, Qingke Kong and his colleagues at the Biodesign Institute at Arizona State University, have developed a technique to make such vaccines safer and more effective. The group, under the direction of Dr. Roy Curtiss,...

7fd987f7838d2c2979d0638f44f6fb98
2011-06-14 05:50:00

$4.3 billion has been pledged by international donors, led by Britain and Bill Gates, to buy vaccines that help protect children in poor countries against life-threatening diseases such as pneumonia and diarrhea, a London conference announced on Monday. Global Alliance for Vaccines and Immunization (GAVI), which is supported by Microsoft's Bill Gates, says the funding would save more than four million lives in the next four years, by providing more than 250 million of the world's poorest...

2011-06-13 09:58:00

LONDON, June 13, 2011 /PRNewswire/ -- - GAVI Alliance Poised to IMMUNISE More Than 250 Million Children in Developing Countries by 2015 Major public and private donors achieved a milestone in global health today by committing funding to immunise more than 250 million of the world's poorest children against life-threatening diseases by 2015 and prevent more than four million premature deaths. (Photo: http://www.newscom.com/cgi-bin/prnh/20110613/461374 )...

2011-05-17 05:00:00

GENEVA, May 17, 2011 /PRNewswire/ -- Bill Gates, co-chair of the Bill & Melinda Gates Foundation, called on government leaders to increase their investments in vaccines and to hold themselves accountable for extending the benefits of vaccines to every child. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/gatesfoundation/49363/ (Photo: http://photos.prnewswire.com/prnh/20110517/MM01624 ) In a keynote address at the 64th...

2011-05-12 10:42:34

Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente study published today in the journal Vaccine. The study's findings challenge information in the zoster vaccine manufacturer's package insert. This new information is important to patients who find it more convenient and less costly to receive both vaccines from their...

2011-05-11 18:00:00

PASADENA, Calif., May 11, 2011 /PRNewswire/ -- Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente study published today in the journal Vaccine. The study's findings challenge information in the zoster vaccine manufacturer's package insert. This new information is important to patients who find it more convenient and...

2011-04-06 11:22:18

Using a cross-sectional study, Stefan Flasche and colleagues investigated the effects of the UK pneumococcal vaccination program on serotype-specific carriage and invasive pneumococcal disease. There are more than 90 Streptococcus pneumoniae serotypes that can cause invasive pneumococcal disease (IPD). The pneumococcal conjugate vaccine PCV7 contains antigens from seven serotypes responsible for IPD. Immunization with PCV7 prevents both IPD disease and carriage of these seven serotypes, but...

2011-03-03 07:00:00

BEIJING, March 3, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011. Sinovac initiated its PCV research program in 2008. The vaccine targets infants under two years old. The target population in China is estimated at 34...

2011-02-22 13:09:48

Triggers protective immune response while preventing fatal inflammation Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases. Pneumococcal pneumonia can occur when the lungs are...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related